Boston Scientific Corporation (BSX): A Hot Growth Stock to Buy According to Hedge Funds
We recently compiled a list of the 8 Hot Growth Stocks To Buy According to Hedge Funds. In this article, we are going to take ...
Axonics’ Q3 2024: Revenue Growth Amid Challenges
Axonics Modulation Technologies ( (AXNX) ) has released its Q3 earnings. Here is a breakdown of the information Axonics Modulation Technologies ...
Zacks.com on MSN4d
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates
Axonics Modulation Technologies (AXNX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.08 per share a year ...
Le Lézard4d
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
Accelerate Diagnostics, Inc. today announced financial results for the third quarter ended September 30, 2024. "We are excited ...
Axonics: Q3 Earnings Snapshot
IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Axonics Modulation Technologies Inc. (AXNX) on Thursday reported a third-quarter loss of $21,000, after reporting a profit in the same period a year earlier ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Outset Medical (OM), Pacira Pharmaceuticals (PCRX) and Allakos (ALLK)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Outset Medical (OM – Research Report), Pacira ...
Axonics' Market Growth Strengthens Boston Scientific's Future
Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...